Advantages |
|
|
|
Simultaneous testing of many predictive biomarkers, saving time and material
High specificity and sensitivity
Identification of several ROS1 fusion partners
Both DNA and RNA as input material
Recent validation of panels for ctDNA
|
Limitations |
|
Variable rates of failure (RNA integrity could be affected by fixation)
Primers require knowledge of possible fusion partners
Missing of uncommon or rare partners
|
|
|